Investigational Site Number 250004

Montpellier 34295

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis Relapse, Neoplasm Malignant

Studies at this site

• Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen — Completed
• Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta — Stopped early